Home > Boards > US Listed > Medical - Drugs >

Petros Pharmaceuticals Inc. (PTPI)

PTPI RSS Feed
Add PTPI Price Alert      Hide Sticky   Hide Intro
Moderator: 136
Search This Board: 
Last Post: 5/20/2022 3:29:13 PM - Followers: 11 - Board type: Free - Posts Today: 0

Petros Pharmaceuticals, Inc. 


Great NEWS :
Petros Pharmaceuticals, Inc. Through Exclusive Marketing Agreement with Hims & Hers Health, Inc. Generates 476% Year-Over-Year Growth of STENDRA Tablet Sales
November 03 2021 - 09:16AM
Full News :  https://www.otcmarkets.com/stock/PTPI/news/story?e&id=2041179

NEW YORK, Nov. 3, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Petros, Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announces a 476% growth year-over-year of STENDRA tablet sales as part of an exclusive digital health marketing agreement with Hims & Hers Health, Inc. ("Hims & Hers" or "Hims"), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers. The companies also announce the availability of additional dosages of STENDRA through the Hims & Hers platform, further expanding the partnership.



Statement of Ownership :        https://www.otcmarkets.com/filing/html?id=15304104&guid=Ig8wkWbB1m4Cdth

Form D:  https://www.otcmarkets.com/filing/html?id=15301358&guid=Ig8wkWbB1m4Cdth





Share Structure

Market Cap Market Cap
28,300,605
11/03/2021
 
 
Outstanding Shares
9,826,599
08/09/2021

Company webpagehttps://www.petrospharma.com/

Petros Company video:
https://vimeo.com/447971685








 
PTPI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PTPI News: Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update 05/16/2022 01:00:00 PM
PTPI News: Quarterly Report (10-q) 05/16/2022 12:37:56 PM
PTPI News: Petros Pharmaceuticals to Pursue 505(B)(2) Pathway for H-100, Company’s Novel Topical Investigational Treatment for Peyronie’s Disease Which Impacts More Than 1 in 10 Men in the US 05/03/2022 05:23:00 AM
PTPI News: Petros Pharmaceuticals to Present at the Planet MicroCap Showcase 2022 04/27/2022 05:25:00 PM
PTPI News: Petros Pharmaceuticals, Inc. Engages Massachusetts General Hospital in a Sponsored Research Agreement for Tissue-Specific Oxygenation Sensor Technology 04/26/2022 05:15:00 AM
PostSubject
#161   How many days below a buck before the runncoach 05/20/22 03:29:13 PM
#160   Nasty sales number again. Spending twice as runncoach 05/16/22 08:51:03 PM
#159   I added some glens0 04/21/22 08:32:30 AM
#158   fda approval comes faster 2nd time,have drug called 81vette 04/20/22 09:26:49 AM
#157   Yeah I still don't think selling here at 136 04/19/22 08:50:30 PM
#156   incredibly awesome call !!!you kicked this bull right 81vette 04/19/22 01:48:54 PM
#155   likes to gap and run 50 to100% after 81vette 04/19/22 01:43:35 PM
#154   PTPI:Plenty Chart Room if they let it go Sibware 04/19/22 12:39:59 PM
#153   zero borrow,no shares to short,could run huge> 81vette 04/19/22 12:27:18 PM
#152   huge runs in past on fluff news,this is huge!! 81vette 04/19/22 12:03:10 PM
#151   1.58 from 1.20 nice open pop G2G 04/19/22 09:38:35 AM
#150   1.20's https://ih.advfn.com/stock-market/NASDAQ/petros-pharmaceuticals-PTPI/sto G2G 04/19/22 09:23:43 AM
#149   Not sure. I just know its hard runncoach 03/31/22 06:16:58 PM
#148   Is the 20M OS listed on this page Nealio 03/31/22 06:10:40 PM
#147   Sales for the ENTIRE year for Stendra were runncoach 03/31/22 05:51:11 PM
#146   Broke $1.60 should shoot for $2 next as tw0122 03/30/22 12:22:50 PM
#145   then the expiries are damning. In the EU VividC 03/25/22 05:22:41 AM
#144   I can't imagine that having an impact on runncoach 03/24/22 06:28:30 PM
#143   Is there an extension of the patents or VividC 03/24/22 06:04:05 PM
#142   Overall market took it lower, I'm in Nealio 03/24/22 04:28:24 AM
#141   I'm still invested here. Pretty significantly I might say 136 03/18/22 12:56:06 PM
#140   I added a lot at 1.14 and 1.19. 136 03/18/22 12:48:10 PM
#139   Technical 8x34 chart looks ready for a move Nealio 03/10/22 04:48:06 PM
#138   Couple months later; could you or 136 give Nealio 03/03/22 07:33:27 PM
#137   I guess all the folks that did their runncoach 01/22/22 09:34:29 AM
#136   Which is why I have been posting runncoach 01/20/22 01:06:11 AM
#135   Anyone that was paying attention for the last 136 01/19/22 11:45:02 PM
#134   Looks like nowhere close to getting the over runncoach 01/19/22 08:33:38 AM
#133   Doubled down today, added 5000 @ 3.05 136 01/04/22 01:52:44 PM
#132   #BFRI ?? #PTPI ?? These 2 stocks could da_stock_analyst 12/26/21 03:06:02 PM
#131   Like the trend my friend here tw0122 12/23/21 11:45:13 AM
#130   #PTPI ?? Why social media considering short squeeze da_stock_analyst 12/17/21 09:04:57 PM
#129   Hey there 136.......being you've been here for a Ripdog7570 12/17/21 02:55:41 PM
#128   Would like to see how it behaves around 136 12/15/21 12:14:55 AM
#127   Wow. 2s already runncoach 12/14/21 03:46:02 PM
#125   Hard to keep all the money raises straight runncoach 12/13/21 04:32:59 PM
#124   PTPI: Last intraday VWAP test done Sibware 12/13/21 03:32:49 PM
#123   How many you think are left? runncoach 12/13/21 02:24:16 PM
#122   im aware 136 12/13/21 12:52:33 PM
#121   Yessir Still holding 5000 @ 2.39 136 12/13/21 12:52:08 PM
#120   They don't trade. They are cashed in and runncoach 12/13/21 09:51:37 AM
#119   $4 aGAIN G2G 12/13/21 09:51:02 AM
#118   Oops. "Out" runncoach 12/13/21 09:48:29 AM
#117   Lol. Check when the patent runs old. runncoach 12/13/21 09:48:04 AM
#116   they don't ? 136 12/13/21 09:47:07 AM
#115   Honestly the newsletter doesn't really have anything to 136 12/13/21 09:44:30 AM
#114   Didn’t realize warrants traded on ptpi A_Keen Greek_Eye 12/13/21 09:37:40 AM
#113   Millions in cheap warrants. They could be the runncoach 12/13/21 09:36:47 AM
#112   Opens closer to three then four, shorts control A_Keen Greek_Eye 12/13/21 08:57:56 AM
#111   Amazing what a penny stock newsletter can do runncoach 12/13/21 08:35:13 AM
PostSubject
Consent Preferences